Skip to main content
CELU
NASDAQ Life Sciences

Celularity's Cenplacel-L Cell Therapy Gains New Florida Pathway for Investigational Use

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$1.02
Mkt Cap
$29.525M
52W Low
$0.71
52W High
$4.35
52W Position info
44% above low
Off High info
77% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

CELU sits 44% above its 52-week low of $0.71.

Summary

Celularity's investigational cell therapy, Cenplacel-L, is now available for physician-directed use in Florida under a new state law, creating a unique regulatory pathway outside traditional federal FDA approval. This partnership with Fountain Life establishes one of the first state-level frameworks for allogeneic cellular therapies, potentially accelerating clinical experience and market expansion for Celularity. This positive product development is particularly significant for the micro-cap biotech, which recently disclosed a going concern warning in April. The ability to deploy a lead asset through this new channel could be crucial for the company's financial stability and future development.

At the time of this announcement, CELU was trading at $1.02 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $29.5M. The 52-week trading range was $0.71 to $4.35. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

CELU - Latest Insights

CELU
Nov 10, 2026, 4:30 PM EST
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $0.720
Real-time Price: $0.6052 info
Change: -$0.1148 (-16%) info
Market Cap: $19.639M info
CELU
Oct 28, 2026, 5:52 PM EDT
Filing Type: PRE 14A
Importance Score:
7
Price at Filing: $0.980
Real-time Price: $0.6052 info
Change: -$0.3748 (-38%) info
Market Cap: $19.639M info
CELU
Oct 20, 2026, 5:08 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $1.26
Real-time Price: $0.6052 info
Change: -$0.6548 (-52%) info
Market Cap: $19.639M info
CELU
Oct 05, 2026, 7:00 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $1.62
Real-time Price: $0.6052 info
Change: -$1.01 (-63%) info
Market Cap: $19.639M info
CELU
Sep 29, 2026, 5:02 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $1.39
Real-time Price: $0.6052 info
Change: -$0.7848 (-56%) info
Market Cap: $19.639M info